Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
© Fluge and Mella; licensee BioMed Central Ltd. 2009
Received: 08 May 2009
Accepted: 01 July 2009
Published: 01 July 2009
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|8 May 2009||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|15 May 2009||Author responded||Author comments - Øystein Fluge|
|Resubmission - Version 3|
|15 May 2009||Submitted||Manuscript version 3|
|26 May 2009||Reviewed||Reviewer Report - Anthony Pinching|
|4 Jun 2009||Reviewed||Reviewer Report - A. Martin Lerner|
|17 Jun 2009||Author responded||Author comments - Øystein Fluge|
|Resubmission - Version 4|
|17 Jun 2009||Submitted||Manuscript version 4|
|29 Jun 2009||Author responded||Author comments - Øystein Fluge|
|Resubmission - Version 5|
|29 Jun 2009||Submitted||Manuscript version 5|
|1 Jul 2009||Editorially accepted|
|1 Jul 2009||Article published||10.1186/1471-2377-9-28|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.